Press releases
- Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease
- Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024
- Avantor® Appoints Corey Walker as President of Laboratory Solutions
- Avantor® Releases 2024 Science for Goodness Sustainability Report
- Avantor® to Participate in Goldman Sachs Global Healthcare Conference
- Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions Conference
- Avantor® to Participate in BofA Securities 2024 Health Care Conference
- Avantor® Reports First Quarter 2024 Results
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 679.27m |
Free float | 656.71m |
P/E (TTM) | 54.92 |
Market cap | 14.27bn USD |
EPS (TTM) | 0.3826 USD |
--
More ▼